Price $3.84 |
Market Cap
346M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
11.6
|
P/B
7.94
|
P/S
0.95
|
Dividend %
-
|
|
P/CF
47.8
|
P/FCF
34.0
|
Op. Cash Flow
18.3K
|
FCF
0.1
|
|
Op. Margin
-0.90%
|
Net Margin
-5.90%
|
ROE
-50.00%
|
ROI
29.40%
|
|
ROA
-6.10%
|
EPS Growth
21.40%
|
Current Ratio
1.7
|
Debt/Equity
269.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vaxart Inc (VXRT) | $3.20 | - | - | 20.3M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 9.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.40 | - | - | 37.2M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.24 | - | - | 65M | Strong Buy |
| Civitas Solutions Inc (CIVI) | $15.78 | - | - | 527.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
